HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ECHA: Non-Animal Tests For Complex Toxicity Endpoints Not 'Foreseeable'

This article was originally published in The Rose Sheet

Executive Summary

Animal-welfare groups are concerned that a new report from the European Chemicals Agency on the regulatory applicability of alternative tests "weighs too heavily on the challenges faced in applying data from non-animal methods." The timing, with the REACH 2018 registration deadline looming, also is worrisome, they suggest.

You may also be interested in...

Cosmetic Ingredient Innovation In An Increasingly Cruelty-Free World; Is It Possible?

Visibility is low into the availability of new cosmetic ingredients since 2013, but there does appear to be a viable pathway for innovations to reach the EU market, despite the animal testing ban, as well as California, where similar prohibitions will go into effect in 2020. Still, industry’s best bet is to continue investing in alternative methods development and promoting their acceptance with regulators.

California’s Cosmetic Animal-Testing Ban Not A Brick Wall, But Proceed With Caution

Animal testing permitted for ingredients in Europe with purposes beyond cosmetics is not necessarily something that would forfeit products’ marketability in California under its Cruelty-Free Cosmetics Act. However, industry should seek guidance on the law’s interpretation from the state’s attorney general.

California’s Cruelty-Free Cosmetics Act Makes New Ingredients Officially Endangered

It’s debatable the extent to which SB 1249, now headed to the governor’s desk, will improve animals’ lot, but cosmetic ingredient innovation is almost certain to suffer. Industry could escalate efforts behind alternative methods development, or there’s another possible solution: federal preemption.

Related Content


Latest News



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts